This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has led to enviable performance over a long period of time. We periodically provide
This post was just published on ZYX Buy Change Alert. BPMC is a recent biotech IPO that was bought in the after market at an average price of $19.20. As of this writing it is trading at $29.20. 40% of the full core position size is being held. Consider taking profits on a
This post was just published on ZYX Buy Change Alert. In view of overall market conditions, especially the negative money flow in biotechs, consider accumulating a maximum of 40% of BPMC. Previous call was to accumulate up to 60%. Please adjust the quantity based on your own risk tolerance. You are
This post was just published on ZYX Buy Change Alert. BPMC is a biotech firm focused on developing cancer treatment therapies. This is a new IPO. It is a high risk high reward situation suitable only for aggressive investors as the risk of loss is high. Here is the plan: Consider buying